Natural polyphenols for the management of autism spectrum disorder: a review of efficacy and molecular mechanisms

References

• Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022;15(5):778–790.
   PubMed Web of Science ®Google Scholar
• Tsai C-H, Chen K-L, Li H-J, Chen K-H, Hsu C-W, Lu C-H, et al. The symptoms of autism including social communication deficits and repetitive and restricted behaviors are associated with different emotional and behavioral problems. Scientific Rep. 2020;10(1):1–8.
   PubMed Web of Science ®Google Scholar
• Currenti SA. Understanding and determining the etiology of autism. Cell Mol Neurobiol. 2010;30(2):161–171.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17(4):389–401.
   PubMed Web of Science ®Google Scholar
• Bjørklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, et al. Oxidative stress in autism spectrum disorder. Mol Neurobiol. 2020;57(5):2314–2332.
   PubMed Web of Science ®Google Scholar
• Wong GC, Montgomery JM, Taylor MW.. The gut-microbiota-brain axis in autism spectrum disorder. In: Grabruker AM, editor. Autism spectrum disorders [internet]. Brisbane (AU): Exon publications; 2021. p. 95–113.
   Google Scholar
• Fieiras C, Chen MH, Liquitay CME, Meza N, Rojas V, Franco JVA, etal Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews. BMJ Evid Based Med. 2023;28(1):7–14.
   PubMedGoogle Scholar
• Pangrazzi L, Balasco L, Bozzi Y. Natural antioxidants: a novel therapeutic approach to autism spectrum disorders?. Antioxidants (Basel). 2020;9(12):1186.
   PubMedGoogle Scholar
• Yahfoufi N, Alsadi N, Jambi M, Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 2018;10(11):1618.
   PubMed Web of Science ®Google Scholar
• Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N. Oxidative stress and inflammation: what polyphenols can do for us?. Oxid Med Cell Longev, 2016;2016:7432797.
   PubMed Web of Science ®Google Scholar
• Singla RK, Dubey AK, Garg A, Sharma RK, Fiorino M, Ameen SM, et al.. Natural polyphenols: chemical classification, definition of classes, subcategories, and structures. J AOAC Int. 2019;102(5):1397–1400.
   PubMed Web of Science ®Google Scholar
• Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727–747.
   PubMed Web of Science ®Google Scholar
• Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, et al. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci. 2012;15(1):1–9.
   PubMed Web of Science ®Google Scholar
• Khalatbary AR. Natural polyphenols and spinal cord injury. Iran Biomed J. 2014;18(3):120–129.
   PubMedGoogle Scholar
• Khalatbary AR. Olive oil phenols and neuroprotection. Nutr Neurosci. 2013;16(6):243–249.
   PubMed Web of Science ®Google Scholar
• Gomez-Pinilla F, Nguyen TT. Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr Neurosci. 2012;15(3):127–133.
   PubMed Web of Science ®Google Scholar
• Xie W, Ge X, Li L, Yao A, Wang X, Li M, et al. Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation. Mol Autism. 2018;9(1):1–13.
   PubMedGoogle Scholar
• Hendouei F, Sanjari Moghaddam H, Mohammadi MR, Taslimi N, Rezaei F, Akhondzadeh S. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial. J Clin Pharm Therap. 2020;45(2):324–334.
   PubMed Web of Science ®Google Scholar
• Zhong H, Xiao R, Ruan R, Liu H, Li X, Cai Y, et al. Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism. Psychopharmacology. 2020;237(12):3539–3552.
   PubMedGoogle Scholar
• Bhandari R, Kuhad A. Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sci. 2015;141:156–169.
   PubMed Web of Science ®Google Scholar
• Bertolino B, Crupi R, Impellizzeri D, Bruschetta G, Cordaro M, Siracusa R, et al. Beneficial effects of co-ultramicronized palmitoylethanolamide/luteolin in a mouse model of autism and in a case report of autism. CNS Neurosci Therap. 2017;23(1):87–98.
   PubMed Web of Science ®Google Scholar
• Tsilioni I, Taliou A, Francis K, Theoharides T. Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry. 2015;5(9):e647–e647.
   PubMed Web of Science ®Google Scholar
• Mehta R, Bhandari R, Kuhad A. Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway. Psychopharmacology. 2021;238(11):3249–3271.
   PubMed Web of Science ®Google Scholar
• Trovò L, Fuchs C, De Rosa R, Barbiero I, Tramarin M, Ciani E, et al. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo. Neurobiol Dis. 2020;138:104791.
   PubMed Web of Science ®Google Scholar
• Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agricult Food Chem. 2002;50(11):3337–3340.
   PubMed Web of Science ®Google Scholar
• Tellone E, Galtieri A, Russo A, Giardina B, Ficarra S. Resveratrol: a focus on several neurodegenerative diseases. Oxid Med Cell Longev, 2015;2015:392169.
   PubMed Web of Science ®Google Scholar
• Neves R, Lucio M, Lima LC, Reis S. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Medic Chem. 2012;19(11):1663–1681.
   PubMed Web of Science ®Google Scholar
• Bambini-Junior V, Zanatta G, Nunes GDF, de Melo GM, Michels M, Fontes-Dutra M, et al. Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci Lett. 2014;583:176–181.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Alzahrani MZ, Nadeem A, Ansari MA, Zoheir KM, Attia SM, et al. Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+ tf/J mouse model of autism. Mol Cell Neurosci. 2016;77:1–10.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Alzahrani MZ, Ansari MA, Nadeem A, Zoheir K, Attia SM, et al. Resveratrol ameliorates dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in a BTBR T+ tf/J mouse model of autism. Mol Neurobiol. 2017;54(7):5201–5212.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kuhad A. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders. Neurochem Intern. 2017;103:8–23.
   PubMed Web of Science ®Google Scholar
• Fontes-Dutra M, Santos-Terra J, Deckmann I, Brum Schwingel G, Della-Flora Nunes G, Hirsch MM, et al. Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid. Front Synaptic Neurosci. 2018;10:9.
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Ansari MA, Nadeem A, Alzahrani MZ, Bakheet SA, Attia SM. Resveratrol improves neuroimmune dysregulation through the inhibition of neuronal toll-like receptors and COX-2 signaling in BTBR T+ Itpr3tf/J mice. Neuromol Med. 2018;20(1):133–146.
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alzahrani MZ, Alshammari MA, et al. Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T+ Itpr3tf/J autistic mice. Eur J Pharmacol. 2018;829:70–78.
   PubMed Web of Science ®Google Scholar
• Juybari KB, Sepehri G, Meymandi MS, Shahrbabaki SSV, Moslemizadeh A, Saeedi N, et al. Sex dependent alterations of resveratrol on social behaviors and nociceptive reactivity in VPA-induced autistic-like model in rats. Neurotoxicol Teratol. 2020;81:106905.
   PubMed Web of Science ®Google Scholar
• Hidema S, Kikuchi S, Takata R, Yanai T, Shimomura K, Horie K, Nishimori K. Single administration of resveratrol improves social behavior in adult mouse models of autism spectrum disorder. Biosci Biotechnol Biochem. 2020;84(11):2207–2214.
   PubMed Web of Science ®Google Scholar
• Deckmann I, Santos-Terra J, Fontes-Dutra M, Körbes-Rockenbach M, Bauer-Negrini G, Schwingel GB, et al. Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model. Intern J Develop Neurosci. 2021;81(7):579–604.
   PubMed Web of Science ®Google Scholar
• Santos-Terra J, Deckmann I, Schwingel GB, Paz AVC, Gama CS, Bambini-Junior V, et al. Resveratrol prevents long-term structural hippocampal alterations and modulates interneuron organization in an animal model of ASD. Brain Res. 2021;1768:147593.
   PubMed Web of Science ®Google Scholar
• Santos-Terra J, Deckmann I, Carello-Collar G, Nunes GD-F, Bauer-Negrini G, Schwingel GB, et al. Resveratrol prevents cytoarchitectural and interneuronal alterations in the valproic acid Rat model of autism. Intern J Mol Sci. 2022;23(8):4075.
   PubMed Web of Science ®Google Scholar
• Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin—from molecule to biological function. Angew Chem Intern Ed. 2012;51(22):5308–5332.
   PubMed Web of Science ®Google Scholar
• Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004;74(8):969–985.
   PubMed Web of Science ®Google Scholar
• Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, Sakharkar MK. Benefits of curcumin in brain disorders. BioFactors. 2019;45(5):666–689.
   PubMed Web of Science ®Google Scholar
• Al-Askar M, Bhat RS, Selim M, Al-Ayadhi L, El-Ansary A. Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism. BMC Compl Altern Med. 2017;17(1):1–11.
   PubMedGoogle Scholar
• Jayaprakash P, Isaev D, Shabbir W, Lorke DE, Sadek B, Oz M. Curcumin potentiates α7 nicotinic acetylcholine receptors and alleviates autistic-like social deficits and brain oxidative stress status in mice. Intern J Mol Sci. 2021;22(14):7251.
   PubMed Web of Science ®Google Scholar
• Lin Y, Shi R, Wang X, Shen H-M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targ. 2008;8(7):634–646.
   PubMed Web of Science ®Google Scholar
• Tesio AY, Robledo SN. Analytical determinations of luteolin. BioFactors. 2021;47(2):141–164.
   PubMed Web of Science ®Google Scholar
• Zhou P, Li L-P, Luo S-Q, Jiang H-D, Zeng S. Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin. J Agricult Food Chem. 2008;56(1):296–300.
   PubMed Web of Science ®Google Scholar
• López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009;9(1):31–59.
   PubMed Web of Science ®Google Scholar
• Parker-Athill E, Luo D, Bailey A, Giunta B, Tian J, Shytle RD, et al. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J Neuroimmunol. 2009;217(1-2):20–27.
   PubMed Web of Science ®Google Scholar
• Asadi S, Theoharides TC. Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. J Neuroinflam. 2012;9(1):1–6.
   PubMedGoogle Scholar
• Zuiki M, Chiyonobu T, Yoshida M, Maeda H, Yamashita S, Kidowaki S, et al. Luteolin attenuates interleukin-6-mediated astrogliosis in human iPSC-derived neural aggregates: a candidate preventive substance for maternal immune activation-induced abnormalities. Neurosci Lett. 2017;653:296–301.
   PubMed Web of Science ®Google Scholar
• Sutherland BA, Rahman RM, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem. 2006;17(5):291–306.
   PubMed Web of Science ®Google Scholar
• Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 2002;56(12):1186–1193.
   PubMed Web of Science ®Google Scholar
• Khalatbary AR, Khademi E. The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection. Nutr Neurosci. 2020;23(4):281–294.
   PubMed Web of Science ®Google Scholar
• Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem. 2004;15(9):506–516.
   PubMed Web of Science ®Google Scholar
• Banji D, Banji OJ, Abbagoni S, Hayath MS, Kambam S, Chiluka VL. Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res. 2011;1410:141–151.
   PubMed Web of Science ®Google Scholar
• Batiha G, Beshbishy A, Mulla Z, Ikram M, El-Hack M, Taha A, Elewa Y. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods. 2020;9(3):374.
   PubMed Web of Science ®Google Scholar
• Tamtaji OR, Hadinezhad T, Fallah M, Shahmirzadi AR, Taghizadeh M, Behnam M, Asemi Z. The therapeutic potential of quercetin in Parkinson’s disease: insights into its molecular and cellular regulation. Curr Drug Targ. 2020;21(5):509–518.
   PubMed Web of Science ®Google Scholar
• Suganthy N, Devi KP, Nabavi SF, Braidy N, Nabavi SM. Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions. Biomed Pharmacother. 2016;84:892–908.
   PubMed Web of Science ®Google Scholar
• Batiha GE-S, Beshbishy AM, Ikram M, Mulla ZS, El-Hack MEA, Taha AE, et al. The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods. 2020;9(3):374.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Masubuchi Y, Okada R, Nakajima K, Nakamura K, Masuda S, et al. Ameliorating effect of postweaning exposure to antioxidant on disruption of hippocampal neurogenesis induced by developmental hypothyroidism in rats. J Toxicol Sci. 2019;44(5):357–372.
   PubMedGoogle Scholar
• de Mattos B, Soares MSP, Spohr L, Pedra NS, Teixeira FC, de Souza AA, et al. Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism. Intern J Develop Neurosci. 2020;80(4):287–302.
   PubMed Web of Science ®Google Scholar
• Okano H, Takashima K, Takahashi Y, Ojiro R, Tang Q, Ozawa S, et al. Ameliorating effect of continuous alpha-glycosyl isoquercitrin treatment starting from late gestation in a rat autism model induced by postnatal injection of lipopolysaccharides. Chem Biol Interact. 2022;351:109767.
   PubMed Web of Science ®Google Scholar
• Evans JA, Mendonca P, Soliman KF. Neuroprotective effects and therapeutic potential of the citrus flavonoid hesperetin in neurodegenerative diseases. Nutrients. 2022;14(11):2228.
   PubMed Web of Science ®Google Scholar
• Khalaj R, Moghaddam AH, Zare M. Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism. Intern J Develop Neurosci. 2018;69:80–87.
   PubMed Web of Science ®Google Scholar
• Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. Neuroprotective and cognitive enhancement potentials of baicalin: a review. Brain Sci. 2018;8(6):104.
   PubMed Web of Science ®Google Scholar
• Elesawy RO, El-Deeb OS, Eltokhy AK, Arakeep HM, Ali DA, Elkholy SS, et al. Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: The possible implication of sirtuin-1/mitofusin-2/Bcl-2 pathway. Biomed Pharmacother. 2022;150:112960.
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Vinothkumar V, Murali R: Antidiabetic efficacy of citrus fruits with special allusion to flavone glycosides. In Bioactive food as dietary interventions for diabetes (Second Edition). GT: Elsevier; 2019, 335–346.
   Google Scholar
• Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Pharmacology of diosmin, a citrus flavone glycoside: an updated review. Eur J Drug Metab Pharmacokinet. 2022;47(1):1–18.
   PubMed Web of Science ®Google Scholar
• Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherited Metab Dis. 2010;33(5):469–477.
   PubMed Web of Science ®Google Scholar
• Barone R, Bastin J, Djouadi F, Singh I, Karim MA, Ammanamanchi A, et al. Mitochondrial fatty acid β-oxidation and resveratrol effect in fibroblasts from patients with autism spectrum disorder. J Personal Med. 2021;11(6):510.
   PubMed Web of Science ®Google Scholar
• Theoharides T, Asadi S, Panagiotidou S. A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders. vol. 25. London: SAGE Publications Sage UK; 2012, 317–323.
   Google Scholar
• Taliou A, Zintzaras E, Lykouras L, Francis K. An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin Therap. 2013;35(5):592–602.
   PubMed Web of Science ®Google Scholar
• Ekici B. Combination of steroid and flavonoid for the treatment of regressive autism. J Neurosci Rural Pract. 2020;11(01):216–218.
   PubMedGoogle Scholar